Optimum Investment Advisors Reata Pharmaceuticals Inc Transaction History

Optimum Investment Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 08, 2022	SELL	$24.12 - $39.6 $14,857 - $24,393	-616 Reduced 99.68%	2 $0
Q2 2021 Aug 02, 2021	SELL	$78.27 - $151.29 $2,269 - $4,387	-29 Reduced 4.48%	618 $87,000
Q4 2020 Jan 21, 2021	SELL	$102.03 - $184.62 $62,136 - $112,433	-609 Reduced 48.49%	647 $80,000
Q3 2020 Oct 06, 2020	BUY	$93.53 - $163.34 $48,822 - $85,263	522 Added 71.12%	1,256 $122,000
Q1 2020 Apr 21, 2020	SELL	$124.16 - $247.74 $33,895 - $67,633	-273 Reduced 27.11%	734 $106,000
Q4 2019 Jan 22, 2020	BUY	$74.57 - $217.92 $14,913 - $43,584	200 Added 24.78%	1,007 $206,000
Q3 2019 Oct 17, 2019	BUY	$71.26 - $95.75 $142 - $191	2 Added 0.25%	807 $65,000
Q2 2019 Jul 29, 2019	BUY	$77.72 - $94.35 $62,564 - $75,951	805 New	805 $76,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Optimum Investment Advisors with notifications on news.